Tag Archives: oncology

FYR Bio secured $8 million to advance oncology and neuroscience programs using extracellular vesicles, enabling noninvasive biomarker discovery for brain...

Mercy BioAnalytics secured $59 million in series B financing to advance extracellular vesicles-based liquid biopsy tests, including its Halo ovarian cancer screening portfolio, which shows exceptional sensitivity for early detection and promises expanded applications in multi-cancer and lung cancer screening...

Exousia Pro’s acquisition of Exousia AI expands its focus on exosomes as powerful extracellular vesicles for oncology, dermatology, and drug delivery, with...

Aethlon Medical’s Hemopurifier® is a blood filtration device designed to remove extracellular vesicles (EVs) and harmful microRNAs from biological fluids. A new study in Transplant Immunology demonstrates its potential in kidney transplantation by reducing EVs linked to renal dysfunction, highlighting its broader...

Exosomes are extracellular vesicles produced by all cells with a remarkable ability to efficiently transfer genetic material, including exogenously loaded siRNA, to cancer cells. Here, researchers at MD Anderson Cancer Center report on a bioreactor-based...

Cambridge, MA – December 11, 2017 – Codiak POSITION DESCRIPTION Codiak BioSciences is a venture-backed start-up dedicated to harnessing the power of exosomes as both therapeutics and...

The fusion of plasma membrane with the internal vesicle fusion leads to the secretion of nanovescicles called exosomes into the extracellular environment. The exosomes are released in easily accessible body fluids such as urine and blood and hence acts as ...

Director, Oncology (ref#CB-1010) Cambridge, MA – March 14, 2017 – Codiak POSITION DESCRIPTION Codiak BioSciences is seeking an experienced professional to lead the oncology/immuno-oncology programs at Codiak.  The Director, Oncology will have extensive experience with in vitro and in vivo ...

The University of Texas MD Anderson Cancer Center and Guardant Health today announced a multi-year partnership designed to accelerate comprehensive liquid biopsy technology into the standard of care in cancer treatment. The commercial, research and development agreement will make MD ...

Job ID 199898BR Posting Title VP, Global HD-Translational Precision Oncology COE-(TPO-CoE) Division PHARMA Business Unit ONCOLOGY BU – NPH Country USA Work Location East Hanover, NJ Company/Legal Entity Novartis Pharmaceuticals Functional Area Research & Development Job Type Full Time Employment ...